Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer. [electronic resource]
Producer: 20190722Description: 7-13 p. digitalISSN:- 1527-7755
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Disease-Free Survival
- Fatigue -- chemically induced
- Female
- Fever -- chemically induced
- Humans
- Imidazoles -- administration & dosage
- Male
- Middle Aged
- Mutation
- Nausea -- chemically induced
- Neoplasm Metastasis
- Oximes -- administration & dosage
- Proto-Oncogene Proteins B-raf -- genetics
- Pyridones -- administration & dosage
- Pyrimidinones -- administration & dosage
- Thyroid Carcinoma, Anaplastic -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.